Company Filing History:
Years Active: 2025
Title: Gregory Lawrence Lackner: Innovator in Neurological Research
Introduction
Gregory Lawrence Lackner is an accomplished inventor based in Indianapolis, IN (US). He is currently associated with Eli Lilly and Company, where he contributes to advancements in neurological research. Despite having no granted patents, his work is significant in the field of RNA interference agents.
Latest Patent Applications
Gregory Lackner's latest patent applications include:
1. **SARM1 RNAi AGENTS** - This application provides SARM1 RNAi agents and compositions comprising a SARM1 RNAi agent. It also outlines methods for using these agents in reducing SARM1 expression and treating SARM1-mediated neurological diseases.
2. **SARM1 RNA INTERFERENCE AGENTS** - This application details SARM1 RNAi agents and compositions, along with methods for reducing SARM1 expression, reducing axon degeneration, and treating SARM1-mediated neurological diseases in subjects.
Conclusion
Gregory Lawrence Lackner is a notable figure in the realm of neurological research, focusing on innovative solutions through RNA interference agents. His contributions, although not yet reflected in granted patents, hold promise for future advancements in treating neurological conditions.